Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Case Reports in Endocrinology is Scopus-indexed (Q4, CiteScore 1.3), WoS ESCI, DOAJ. Published by John Wiley and Sons Ltd.
Checked against the index lists dated .
ISSN 2090-6501Verify ISSN ↗2090-651XVerify ISSN ↗
Publisher: John Wiley and Sons Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Endocrinology, Diabetes and Metabolism | 196 / 250 | 21st | Q4 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2013–present, best quartile Q4, CiteScore 1.3.
Case Reports in Endocrinology is Q4 in Endocrinology, Diabetes and Metabolism (rank 196 of 250), by CiteScore 2025.
Case Reports in Endocrinology is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 1.3, which places it in quartile Q4 at the 21st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.250, quartile Q4, with an H-index of 14.
The publisher lists an article processing charge of about US$870 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Case Reports in Endocrinology is published by John Wiley and Sons Ltd. Its print ISSN is 2090-6501 and its online ISSN is 2090-651X.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Case Reports in Endocrinology has an h-index of 23 and a 2-year mean of 0.62 citations per paper (OpenAlex). Its Scopus CiteScore is 1.3, quartile Q4. On 2-year citations it ranks #192 of 246 Scopus journals in Endocrinology, Diabetes and Metabolism.
Case Reports in Endocrinology published 56 papers in 2025; its busiest recent year was 2021 with 76. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2025–2026), authors are most often from United States (22.6%), Japan (12.1%) and Australia (8.1%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (2.5 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.